{"retracted":false,"update":{"timestamp":1387065600000,"doi":"10.1016/j.bmcl.2013.10.023","type":"err"},"doi":"10.1016/j.bmcl.2012.11.046","journal":"Bioorganic & Medicinal Chemistry Letters","publisher":"Elsevier BV","title":"Corrigendum to “Development of an in vivo active, dual EP1 and EP3 selective antagonist based on a novel acyl sulfonamide bioisostere” [Bioorg. Med. Chem. Lett. 23 (2013) 37–41]"}
